Literature DB >> 16294277

Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.

Akira Fukuda1, Atsuhiko Hikita, Hidetoshi Wakeyama, Toru Akiyama, Hiromi Oda, Kozo Nakamura, Sakae Tanaka.   

Abstract

UNLABELLED: The role of Rac1 in osteoclast survival and bone-resorbing activity was examined using adenovirus vector expression systems. Rac1 is critically involved in M-CSF receptor signaling and mediates survival signaling primarily through PI3K/Akt pathways. Rac1 also plays a significant role in bone resorptive activity, probably by regulating the motility of osteoclasts.
INTRODUCTION: Rac1 is a member of Rho family small G-proteins, and recent studies have revealed that it mediates anti-apoptotic signals in some types of cells. Rac1 is reported to be required for the cytoskeletal organization and bone-resorbing activity of osteoclasts, but their roles in osteoclast survival and function are not fully elucidated.
MATERIALS AND METHODS: We constructed the adenovirus vector carrying cDNA of either the dominant negative Rac1 (Rac1(DN)) or constitutively active Rac1 (Rac1(CA)) gene, and osteoclast-like cells (OCLs) generated in mouse co-culture system were infected with these viruses. To examine the role of Rac1 in osteoclast survival and function, we performed pit formation assays, survival assays, and Western blotting, including an activated-Rac1 pull-down assay using adenovirus-infected OCLs. To further clarify the mechanism of Rac1 regulation in osteoclast survival, some specific inhibitors and adenovirus vectors of signal transduction molecules were used. To quantify membrane movement before and after macrophage colony-stimulating factor (M-CSF) treatment, OCLs expressing either enhanced green fluorescent protein (EGFP) or Rac1(DN) were recorded with a time-lapse video microscope.
RESULTS: Adenovirus vector-mediated dominant negative Rac1 (Rac1(DN)) expression significantly reduced pit formation, and promoted their apoptosis. M-CSF rapidly activated Rac1, and the prosurvival effect of M-CSF for OCLs was abrogated by Rac1(DN) overexpression. Constitutively active Rac1 enhanced OCL survival, which was completely suppressed by phosphatidylinositol 3'-kinase (PI3K) inhibitors, whereas a Mek inhibitor had only partial effect. Rac1(DN) also partially blocked the activation of Akt induced by the overexpressing catalytic subunit of PI3K. Using time-lapse video microscopy, we found that Rac1(DN) expression reduced membrane ruffling and the spreading of OCLs in response to M-CSF.
CONCLUSIONS: Small guanosine triphosphatase (GTPase) Rac1 is critically involved in M-CSF receptor signaling and mediates survival signaling of osteoclasts primarily by modulating PI3K/Akt pathways. Rac1 also plays a significant role in the bone resorptive activity of cells, probably by regulating the motility of osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16294277     DOI: 10.1359/JBMR.050816

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

1.  Rac deletion in osteoclasts causes severe osteopetrosis.

Authors:  Monica Croke; F Patrick Ross; Matti Korhonen; David A Williams; Wei Zou; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2011-11-23       Impact factor: 5.285

2.  Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

Authors:  Yuji Ito; Steven L Teitelbaum; Wei Zou; Yi Zheng; James F Johnson; Jean Chappel; F Patrick Ross; Haibo Zhao
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

3.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

4.  Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation.

Authors:  Xiuping Zhou; Jinming Qian; Lei Hua; Qiong Shi; Zhi Liu; Yinfu Xu; Ben Sang; Jianbing Mo; Rutong Yu
Journal:  J Mol Neurosci       Date:  2012-10-17       Impact factor: 3.444

Review 5.  Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Authors:  Heiani Touaitahuata; Anne Blangy; Virginie Vives
Journal:  Small GTPases       Date:  2014-03-10

6.  Deleting Rac1 improves vertebral bone quality and resistance to fracture in a murine ovariectomy model.

Authors:  J K R S Magalhaes; M D Grynpas; T L Willett; M Glogauer
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

7.  A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss.

Authors:  Hisako Hikiji; Satoshi Ishii; Takehiko Yokomizo; Tsuyoshi Takato; Takao Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

Review 8.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

9.  Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts.

Authors:  Zhiyong Zeng; Chenqing Zhang; Junmin Chen
Journal:  J Bone Miner Metab       Date:  2013-03-24       Impact factor: 2.626

10.  A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis.

Authors:  Joana Rf Abreu; Wendy Dontje; Sarah Krausz; Daphne de Launay; Paula B van Hennik; Anne-Marieke van Stalborch; Jean-Paul Ten Klooster; Marjolein E Sanders; Kris A Reedquist; Margriet J Vervoordeldonk; Peter L Hordijk; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2010-01-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.